OCCC tumors with MSI-H are highly immunogenic, exhibiting increased tumor-infiltrating lymphocytes (TILs) and elevated PD-L1 expression, which may predict enhanced responsiveness to immune checkpoint blockade (ICB) therapies (71, 73, 74). This evidence concerns the gene CD274 and neoplasm.